REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/03/2026
Back to search
Official data from USPTO
MY IPS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MY IPS
ST13
US500000079294235Class
1, 5, 39, 42, 44
Filing
79294235
Registration
6436457
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
08/03/2026
Trademark type
Word
Nice classes
1, 5, 39, 42, 44
Filing date
01/30/2020
Registration date
08/03/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/03/2021
Last transaction
08/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
JP
Examiner
WEIGLE, KATHERINE CONNOLLY
Law office
L10
Current location
TMEG LAW OFFICE 101
Holders and representatives
Holders
C. F. (pessoa física)
Representatives
Dawn Rudenko Holland & Knight LLP
Technical classification
Nice Classes
Class 1Class 5Class 39Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Stem cells for research and scientific purposes; stem cellsother than for medical or veterinary purposes; chemicals used in industry; plant growth regulating preparations; fertilizers; chemical test paperother than for medical purposes
Class 5
Stem cells for medical and clinical purposes; pharmaceutical preparations for use in regenerative therapy; test paperreagent paper for medical purposes
Class 39
Storage of frozen living cells; storage of tissuescells and stem cells; warehousing services for deposited articles
Class 42
Research in the field of stem cells; commissioned cell cultures for scientific purposescustom design and development of cell cultures for scientific use; cell or gene examination in the nature of research on cells and genes; testing and examination on cells; research and development in the field of cells; testingexaminationresearch and development in the field of regenerative medicine; testingexaminationresearch and development of pharmaceuticals; scientific research in the field of culture of cells for transplantation collected from a patient itself; clinical study in the medical field; providing quality assurance services in the field of cells; quality control for others; providing information on medical research in the field of medical therapy; providing information on testinginspectionresearch related to medical science using stem cells; providing information related to research and development of pharmaceutical preparations; scientific testinganalysisresearch on treatment method and treatment technique related to medical care; testinginspection or research of cosmetics or foods; design and development of computer hardware and computer software for use in the field of medical science; designing of machinesapparatusinstrumentsincluding their partssystems composed of such machinesapparatus and instruments; designdevelopment or maintenance of computer programs; testing the functionality of machinesapparatusinstruments or research on machines apparatusinstruments; rental of laboratory apparatus and instruments
Class 44
Stem cell therapy; providing medical information in the field of cells; providing medical information on regenerative medicine; providing medical information; collection and preservation of biological tissuesblood and cells; medical treatment and diagnosis in the nature of regenerative therapy by culture of medical and clinical cells; medical care; providing information and data for diagnosis and medical treatment in the nature of medical information; medical treatment or diagnosis in the nature of regenerative therapy using regenerative medicine; medical treatment or diagnosis in the nature of regenerative cell therapy; medical treatment in the nature of regenerative therapy; professional medical consulting services in the field of cell preparations to treat diseases; preservation of human blood for use as a supply source of stem cells; clinical examination in the nature of medical examination services; provision of patient clinical medical information and medical record analysis for use in medical treatmentdiagnosis and prevention; medical treatment in the nature of regenerative therapy using cultured cells; preparation and dispensing of medications; physical examination services; dentistry services; providing health information; dietary and nutritional guidance; rental of medical apparatus; commissioned cell culture services for medical purposes
Publications
History of USPTO decisions and trademark events.
31 publications found
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
07/26/2022
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
07/25/2022
PLGL
ASSIGNED TO PARALEGAL
07/25/2022
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
03/25/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/10/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/22/2021
FIMP
FINAL DISPOSITION PROCESSED
12/22/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/26/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/03/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/03/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/18/2021
PUBO
PUBLISHED FOR OPPOSITION
05/18/2021
GPNX
NOTIFICATION PROCESSED BY IB
05/17/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/28/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/28/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/28/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/13/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/12/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/12/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/12/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/27/2020
RFNT
REFUSAL PROCESSED BY IB
11/22/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/29/2020
RFRR
REFUSAL PROCESSED BY MPU
10/29/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/06/2020
CNRT
NON-FINAL ACTION WRITTEN
10/05/2020
MAFR
APPLICATION FILING RECEIPT MAILED
10/02/2020
DOCK
ASSIGNED TO EXAMINER
09/28/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/28/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/24/2020
Continuous trademark protection
Get notified about every new filing that threatens MY IPS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.